Pear Therapeutics, Inc. Warrant
PEARW
PEARW was delisted on the 18th of April, 2023.
37 hedge funds and large institutions have $3.67M invested in Pear Therapeutics, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 6 closing their positions.
8% less funds holding
Funds holding: 40 → 37 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
67% less capital invested
Capital invested by funds: $11.2M → $3.67M (-$7.52M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$306K |
| 2 |
FTUS
Flow Traders U.S.
New York
|
+$6.57K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.79K |
| 4 |
DCM
Difesa Capital Management
New York
|
+$709 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$558 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
-$378K |
| 2 |
KCM
Kingstown Capital Management
New York
|
-$158K |
| 3 |
CF
Cantor Fitzgerald
New York
|
-$63K |
| 4 |
KC
Kepos Capital
New York
|
-$40.7K |
| 5 |
DCM
Dupont Capital Management
Wilmington,
Delaware
|
-$13K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
26
HRT Financial
New York
| $2K | -$659 | -1,333 | -7% |
|
27
Jane Street
New York
| $2K | -$599 | -1,213 | -6% |
|
|
BCM
28
BCK Capital Management
Stamford,
Connecticut
| $2K | – | – | – |
|
29
Walleye Capital
New York
| $2K | – | – | – |
|
|
FTUS
30
Flow Traders U.S.
New York
| $2K | +$6.57K | +13,287 | New |
|
|
VI
31
Vestcor Inc
Fredericton,
New Brunswick, Canada
| $1K | – | – | – |
|
32
Walleye Trading
New York
| $1K | – | – | – |
|
|
33
UBS Group
Zurich,
Switzerland
| $1K | +$558 | +1,129 | +11% |
|
|
34
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1K | +$5.79K | +11,725 | New |
|
|
PSAMP
35
P. Schoenfeld Asset Management (PSAM)
New York
| – | -$378K | -477,602 | Closed |
|
|
KCM
36
Kingstown Capital Management
New York
| – | -$158K | -200,000 | Closed |
|
|
CF
37
Cantor Fitzgerald
New York
| – | -$63K | -79,605 | Closed |
|
|
SCC
38
Spring Creek Capital
Wichita,
Kansas
| – | -$26K | -33,333 | Closed |
|
|
DCM
39
Dupont Capital Management
Wilmington,
Delaware
| – | -$13K | -16,666 | Closed |
|
PEARW Hedge Fund Activity: Q2 2022 in Review
37 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q2 2022, worth a combined $3.67M — down 67% from $11.2M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of PEARW and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 3 added.
The largest buyer was LMR Partners, adding an estimated $306K. The largest seller was P. Schoenfeld Asset Management (PSAM), exiting entirely with an estimated $378K sold.
- 37 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q2 2022, down from 40 in Q1 2022.
- Funds reported $3.67M of Pear Therapeutics, Inc. Warrant stock for Q2 2022, down 67% quarter-over-quarter.
- 3 funds opened new Pear Therapeutics, Inc. Warrant positions in Q2 2022 and 6 closed out, a net change of -3 holders.
- The largest Pear Therapeutics, Inc. Warrant buyer in Q2 2022 was LMR Partners, an estimated $306K added.
- The largest Pear Therapeutics, Inc. Warrant seller in Q2 2022 was P. Schoenfeld Asset Management (PSAM), an estimated $378K sold.
Based on aggregated 13F filings for Q2 2022.